Core Viewpoint - Pfizer is set to report its second-quarter 2025 earnings on August 5, with sales and earnings estimates of $13.78 billion and $0.58 per share, respectively. Recent estimates for 2025 earnings have increased slightly from $3.06 to $3.07 per share over the past month [1][7]. Earnings Performance - Pfizer has consistently exceeded earnings expectations in the last four quarters, achieving an average earnings surprise of 43.49%. The most recent quarter saw an earnings surprise of 43.75% [3][7]. Earnings Surprise Prediction - Pfizer has an Earnings ESP of +1.43% and holds a Zacks Rank 3 (Hold), suggesting a potential positive surprise in the upcoming earnings report [4][5]. Sales Expectations - Strong sales from products like Vyndaqel and Padcev are anticipated to counterbalance declines in sales from Eliquis, Ibrance, and Prevnar. The Zacks Consensus Estimate for Eliquis alliance revenues is $1.95 billion, while the estimate for Prevnar family vaccine sales is $1.36 billion [7][9][10]. Impact of Legislation - The redesign of Medicare Part D under the Inflation Reduction Act (IRA) is expected to negatively affect U.S. revenues, particularly for higher-priced drugs such as Vyndaqel and Ibrance [8]. Segment Analysis - In the Primary Care segment, alliance revenues from Eliquis are projected to decline due to IRA-driven lower pricing. In Oncology, Ibrance sales are likely to be impacted by competitive pressures and generic entries, while sales of Xtandi and Lorbrena are expected to rise [9][14]. Product Performance - Sales of the COVID-19 vaccine Comirnaty are expected to have increased, while sales of the antiviral pill Paxlovid are likely to have declined due to lower infection rates. The Zacks Consensus Estimate for Comirnaty revenues is $193 million, while for Paxlovid it is $299 million [11][12]. Valuation and Stock Performance - Pfizer's stock has decreased by 7.5% this year, compared to a 2.9% decline in the industry. The stock is currently trading at a price/earnings ratio of 7.61, which is lower than the industry average of 14.30 and its own 5-year mean of 10.82 [18][21]. Investment Outlook - Despite challenges such as declining COVID-19 product sales and upcoming loss of exclusivity, Pfizer is expected to see growth from key products and cost-cutting measures. The company anticipates savings of $7.7 billion by the end of 2027, and its dividend yield exceeds 7%, making it attractive for value and income investors [24][26][27].

The market expects American Axle & Manufacturing (AXL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 8, might help the stock move higher if these key numbe ...

Okeanis Eco Tankers Corp. (ECO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, ...

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for New Fortress Energy (NFE) due to higher revenues, with actual results being crucial for stock price movement [1][2] Earnings Expectations - The consensus estimate predicts a quarterly loss of $0.29 per share, reflecting a year-over-year change of +29.3% [3] - Expected revenues are $686.21 million, which is a 60.3% increase from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 18.27% lower in the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10] - New Fortress Energy currently holds a Zacks Rank of 4, complicating predictions of an earnings beat [12][13] Historical Performance - In the last reported quarter, New Fortress Energy was expected to post a loss of $0.04 per share but instead reported a loss of -$0.73, resulting in a surprise of -1,725.00% [14] - Over the past four quarters, the company has beaten consensus EPS estimates twice [15] Conclusion - New Fortress Energy does not appear to be a strong candidate for an earnings beat, and investors should consider other factors before making investment decisions [18]

Under Armour (UAA) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on August 8, might help the stock move higher if these key numbers are better than expectation ...

Ur Energy (URG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Gray Media (GTN) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 8, might help the stock move higher if these key numbers are better than expectations. On ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Atmus Filtration Technologies (ATMU) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...

Company Overview - Essent Group (ESNT) is expected to report a year-over-year decline in earnings of 12% with an EPS of $1.68 for the quarter ended June 2025, while revenues are projected to increase by 1.4% to $317.15 million [3][12]. Earnings Expectations - The consensus EPS estimate has been revised down by 0.85% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][12]. - The Earnings ESP for Essent Group is -0.30%, suggesting a lower Most Accurate Estimate compared to the Zacks Consensus Estimate, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Essent Group exceeded the consensus EPS estimate of $1.66 by delivering earnings of $1.69, resulting in a surprise of +1.81% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [14]. Industry Context - In the broader insurance industry, Ambac Financial Group (AMBC) is expected to report a loss of $0.24 per share, reflecting a significant year-over-year decline of 233.3%, with revenues anticipated to drop by 47.1% to $55.59 million [18][19]. - Ambac's consensus EPS estimate has been revised 25% higher recently, leading to a positive Earnings ESP of +12.5%, indicating a likelihood of beating the consensus EPS estimate [19][20].

The market expects TeraWulf Inc. (WULF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 8, might help the stock move higher if these key numbers are better ...